Is Airsupra in shortage in 2026? Get the latest update on Airsupra availability, why it's hard to find, what it costs, and how to get your prescription filled.
If you've been told your pharmacy doesn't have Airsupra, you might assume there's a national shortage. The short answer: no, Airsupra is not in a formal drug shortage as of March 2026. It's not listed on either the FDA's or ASHP's drug shortage databases.
But here's the catch — even though supply exists, actually getting your hands on Airsupra can feel like a shortage. Many pharmacies simply don't stock it, and the ones that do may not always have it readily available. This creates a frustrating gap between what's technically available and what patients can actually access.
Let's break down what's really going on with Airsupra availability in 2026.
The availability challenges with Airsupra come down to a few key factors:
Airsupra was FDA-approved in January 2023 as the first rescue inhaler to combine albuterol (a bronchodilator) with budesonide (an anti-inflammatory corticosteroid). As a first-in-class product, pharmacy adoption has been gradual. Many pharmacies haven't built up regular stocking patterns for it yet.
There's only one manufacturer — AstraZeneca — and no generic competition. This means the supply chain runs through a single source. While AstraZeneca hasn't reported production issues, the lack of alternative manufacturers makes the supply chain less resilient than it is for medications like albuterol, which has multiple generic makers.
At $479-$737 per inhaler without insurance, Airsupra is an expensive item for a pharmacy to keep on the shelf. If a pharmacy only has a few patients requesting it, the financial risk of stocking it may outweigh the benefit — especially for chain pharmacies with tight inventory budgets.
Even with approximately 80% of commercial plans covering Airsupra, many require prior authorization or step therapy. When patients can't get insurance approval quickly, they may give up or switch to alternatives, which further reduces pharmacy demand and stocking incentive.
Here's the pricing landscape for Airsupra:
For a complete breakdown of savings options, read our full guide on how to save money on Airsupra.
A few developments have made Airsupra more accessible compared to when it first launched:
Here are the most effective strategies for locating Airsupra:
Medfinder helps you check which pharmacies near you have Airsupra in stock, saving you from calling every pharmacy in your area.
Most pharmacies can order Airsupra from their wholesaler even if they don't regularly stock it. Expect 1-3 business days for delivery. Ask early — don't wait until your current inhaler is empty.
Independent pharmacies are often more flexible with inventory. Specialty respiratory pharmacies may already carry Airsupra. See our detailed guide on how to find Airsupra in stock near you.
Between AstraZeneca Direct, mail-order pharmacy programs through your insurance, and specialty pharmacy delivery, you may not need to find it locally at all.
Airsupra isn't in shortage, but it's not always easy to find. The combination of being a newer brand-only medication, the high cash price, and inconsistent insurance coverage creates real access barriers for patients. The good news is that availability is improving — more pharmacies are stocking it, more insurance plans are covering it, and AstraZeneca's direct delivery option provides a backup when local pharmacies fall short.
If you're struggling to find Airsupra, start with Medfinder to check local availability. And if you need a backup plan, explore alternatives to Airsupra that your doctor might consider.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
